Effect of the Treatment Period With Erythromycin on Cytochrome P450 3A Activity in Humans-Reference-Cited by-同舟云学术

Effect of the Treatment Period With Erythromycin on Cytochrome P450 3A Activity in Humans

Published:2007-07 Issue:7 Volume:47 Page:871-876
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Okudaira Toshiaki,Kotegawa Tsutomu,Imai Hiromitsu,Tsutsumi Kimiko,Nakano Shigeyuki,Ohashi Kyoichi

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. A potentially hazardous interaction between erythromycin and midazolam;Olkkola;Clin Pharmacol Ther,1993

2. Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam;Zimmermann;Arzneimittel forschung,1996

3. Cytochrome P450 metabolic intermediate complexes from macrolide antibiotics and related compounds;Franklin;Methods Enzymol,1991

4. Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite-complexes: a structure-activity relationship;Delaforge;Biochem Pharmacol,1983

5. Inhibition and induction of cytochrome P450 and the clinical implications;Lin;Clin Pharmacokinet,1998

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism-based inactivation of cytochromes P450: implications in drug interactions and pharmacotherapy;Xenobiotica;2024-08-28

2. Effect of Voriconazole on Tacrolimus Blood Concentration in Renal Transplant Recipients after Voriconazole Discontinuation;Journal of Clinical Pharmacy and Therapeutics;2024-03-13

3. Exploring the impact of ethnicity on drug pharmacokinetics using PBPK models: A case study with lansoprazole in Japanese subjects;British Journal of Clinical Pharmacology;2024-01-16

4. Development and characterization of pFluor50, a fluorogenic-based kinetic assay system for high-throughput inhibition screening and characterization of time-dependent inhibition and inhibition type for six human CYPs;2023-08-17

5. Evidence of potential pro‐haemorrhagic drug interactions between CYP3A4 inhibitors and direct oral anticoagulants: Analysis of the FAERS database;British Journal of Clinical Pharmacology;2023-03-25